|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期2001-04-01 |
|
|
|
|
|
|
最高研发阶段批准上市 |
|
首次获批日期1992-01-21 |
|
|
|
|
|
非在研适应症- |
最高研发阶段批准上市 |
|
首次获批日期1969-01-24 |
Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control Group
The primary objective is to compare the effectiveness of treatment with Sulfamylon® solution as the initial topical moist dressing over meshed autografts following the initial graft procedure on preventing graft loss in a prospective cohort of subjects versus a historical control group in a non-inferiority trial.
An Open-label, Randomized Study Evaluating the Long-term Effects of Metoprolol (MET) Versus Nebivolol (NEB) as Monotherapy or in Combination With Amlodipine or Hydrochlorothiazide for the Treatment of Patients With Hypertension
The purpose of this study is to evaluate long-term safety,tolerability and blood pressure effects of metoprolol versus nebivolol in patients with hypertension. These drugs may be given alone or in combination with other drugs that are commonly used in the treatment of hypertension
A Double-Blind, Randomized, Placebo- and Active-Controlled, Forced Titration Study Evaluating the Effects of Nebivolol on Blood Pressure and Heart Rate in African American Patients With Hypertension
The purpose of this study is to evaluate the effects of nebivolol on blood pressure and heart rate in African American patients with hypertension.
100 项与 Mylan Bertek Pharmaceuticals, Inc. 相关的临床结果
0 项与 Mylan Bertek Pharmaceuticals, Inc. 相关的专利(医药)
100 项与 Mylan Bertek Pharmaceuticals, Inc. 相关的药物交易
100 项与 Mylan Bertek Pharmaceuticals, Inc. 相关的转化医学